The complement anaphylatoxin C5a and its seven-transmembrane segment (7TMS) receptor play an important role in host defense and in a number of inflammation-associated pathologies. The NH2-terminal domain of the C5a receptor (C5aR/CD88) contributes substantially to its ability to bind C5a. Here we show that the tyrosines at positions 11 and 14 of the C5aR are posttranslationally modified by the addition of sulfate groups. The sulfate moieties of each of these tyrosines are critical to the ability of the C5aR to bind C5a and to mobilize calcium. A C5aR variant lacking these sulfate moieties efficiently mobilized calcium in response to a small peptide agonist, but not to C5a, consistent with a two-site model of ligand association in which the tyrosine-sulfated region of the C5aR mediates the initial docking interaction. A peptide based on the NH2 terminus of the C5aR and sulfated at these two tyrosines, but not its unsulfated analogue or a doubly sulfated control peptide, partially inhibited C5a association with its receptor. These observations clarify structural and mutagenic studies of the C5a/C5aR association and suggest that related 7TMS receptors are also modified by functionally important sulfate groups on their NH2-terminal tyrosines.
Skip Nav Destination
Article navigation
7 May 2001
Article|
May 07 2001
Sulfated Tyrosines Contribute to the Formation of the C5a Docking Site of the Human C5a Anaphylatoxin Receptor
Michael Farzan,
Michael Farzan
aDepartment of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Christine E. Schnitzler,
Christine E. Schnitzler
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Natalya Vasilieva,
Natalya Vasilieva
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Doris Leung,
Doris Leung
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Jens Kuhn,
Jens Kuhn
aDepartment of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Craig Gerard,
Craig Gerard
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Norma P. Gerard,
Norma P. Gerard
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Hyeryun Choe
Hyeryun Choe
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Michael Farzan
aDepartment of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Christine E. Schnitzler
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Natalya Vasilieva
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Doris Leung
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Jens Kuhn
aDepartment of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Craig Gerard
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Norma P. Gerard
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Hyeryun Choe
bPerlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Abbreviations used in this paper: CCR5, CC chemokine receptor 5; Cha, cyclohexylalanine; NMR, nuclear magnetic resonance; 7TMS, seven-transmembrane segment.
Received:
January 25 2001
Revision Requested:
March 19 2001
Accepted:
March 27 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 193 (9): 1059–1066.
Article history
Received:
January 25 2001
Revision Requested:
March 19 2001
Accepted:
March 27 2001
Citation
Michael Farzan, Christine E. Schnitzler, Natalya Vasilieva, Doris Leung, Jens Kuhn, Craig Gerard, Norma P. Gerard, Hyeryun Choe; Sulfated Tyrosines Contribute to the Formation of the C5a Docking Site of the Human C5a Anaphylatoxin Receptor. J Exp Med 7 May 2001; 193 (9): 1059–1066. doi: https://doi.org/10.1084/jem.193.9.1059
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement